|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Outsourcing Outlook: Truth in Outsourcing
Author(s)Jim Miller, William Bierce
by William Bierce and Jim Miller Is that great deal too good to be true?
Advertisement
Articles in this issue
about 24 years ago
Business Matters: Eclipsed by Catastropheabout 24 years ago
Designs for Bioassays with Plate Location Effectsabout 24 years ago
Liposomes (a Review), Part One: Manufacturing Issuesabout 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific SoftwareNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5